SESSION DESCRIPTION
Transcriptional and epigenetic remodelling orchestrate immune evasion and create therapeutic vulnerabilities in lymphoid malignancies, by providing lineage platicity and competitive fitness, inducing extracellular vesicles secretion to modulate the immune microenvironment, downregulating endogenous retroelements, and reorganizing enhancer condensates.
KEYWORDS
Technology and Procedures, Assays, Imaging, Molecular Testing, Omics Technologies, Bioinformatics, Cell Expansion, Gene Editing, Profiling, Treatment Considerations, Combination Therapy, Biological Therapies, Artificial Intelligence (AI), Machine Learning, Biological Processes, Pathogenesis, Genomics, Hematopoiesis, Immune Mechanism, Metabolism, Molecular Biology, Diseases, Genetic Disorders, Lymphoid Malignancies, Lymphoid Leukemias, Lymphomas, Myeloid Malignancies, Acute Myeloid Malignancies, ALL, CLL, Non-Hodgkin Lymphoma, B Cell Lymphoma, Research, Fundamental Science, Translational Research, Study Population, Human, Pediatric, Animal Model